- Home
- MBNKP vs GNLX Comparison
MBNKP vs GNLX Comparison
Compare MBNKP & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBNKP
- GNLX
- Stock Information
- Founded
- MBNKP N/A
- GNLX 2001
- Country
- MBNKP United States
- GNLX United States
- Employees
- MBNKP N/A
- GNLX N/A
- Industry
- MBNKP Commercial Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- MBNKP Finance
- GNLX Health Care
- Exchange
- MBNKP Nasdaq
- GNLX Nasdaq
- Market Cap
- MBNKP N/A
- GNLX 81.5M
- IPO Year
- MBNKP 2019
- GNLX 2023
- Fundamental
- Price
- MBNKP $25.13
- GNLX $2.41
- Analyst Decision
- MBNKP
- GNLX Strong Buy
- Analyst Count
- MBNKP 0
- GNLX 4
- Target Price
- MBNKP N/A
- GNLX $18.25
- AVG Volume (30 Days)
- MBNKP N/A
- GNLX 103.3K
- Earning Date
- MBNKP N/A
- GNLX 11-14-2024
- Dividend Yield
- MBNKP N/A
- GNLX N/A
- EPS Growth
- MBNKP N/A
- GNLX N/A
- EPS
- MBNKP N/A
- GNLX N/A
- Revenue
- MBNKP N/A
- GNLX $8,000.00
- Revenue This Year
- MBNKP N/A
- GNLX N/A
- Revenue Next Year
- MBNKP N/A
- GNLX N/A
- P/E Ratio
- MBNKP N/A
- GNLX N/A
- Revenue Growth
- MBNKP N/A
- GNLX N/A
- 52 Week Low
- MBNKP N/A
- GNLX $1.60
- 52 Week High
- MBNKP N/A
- GNLX $14.74
- Technical
- Relative Strength Index (RSI)
- MBNKP 44.98
- GNLX 45.99
- Support Level
- MBNKP $24.96
- GNLX $2.30
- Resistance Level
- MBNKP $25.48
- GNLX $2.53
- Average True Range (ATR)
- MBNKP 0.21
- GNLX 0.17
- MACD
- MBNKP 0.01
- GNLX 0.01
- Stochastic Oscillator
- MBNKP 58.75
- GNLX 54.90
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.